BioNexus Gene Lab (BGLC) Interest Expenses (2021 - 2026)

BioNexus Gene Lab has disclosed Interest Expenses across 6 years of filings, most recently posting $3085.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $3085.0, down 37.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $17718.0 (down 17.18% YoY), and the FY2025 annual result was $19542.0, down 7.59% from the prior year.
• Interest Expenses came in at $3085.0 for Q1 2026 at BioNexus Gene Lab, down from $3272.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $6482.0 in Q3 2025 to a low of -$4762.0 in Q4 2022.
• The 5-year median for Interest Expenses is $4183.0 (2023), against an average of $2678.8.
• Peak annual rise in Interest Expenses reached 305.55% in 2023, while the deepest fall reached 231.18% in 2023.
• BioNexus Gene Lab's Interest Expenses stood at -$4762.0 in 2022, then jumped by 187.84% to $4183.0 in 2023, then surged by 38.94% to $5812.0 in 2024, then plunged by 43.7% to $3272.0 in 2025, then slipped by 5.72% to $3085.0 in 2026.
• The last three Interest Expenses figures came in at $3085.0 (Q1 2026), $3272.0 (Q4 2025), and $6482.0 (Q3 2025), per Business Quant data.